Search and analyze individual stocks with comprehensive metrics

Roopa Industries

ROOPAINDPharmaceuticals & Biotechnology

Fundamental Score

...

Roopa Industries Share Price & Market Analysis

Current Market Price (CMP)
56.29
No change data available
Market Cap
44.66 (Cr)
Industry
Pharmaceuticals & Biotechnology

Profitability Metrics

Poor

Return on Equity

12.07%
Poor

Return on Capital Employed

11.96%
Poor

Operating Profit Margin (5Y)

5.36%
Poor

Dividend Yield

0.00%

Valuation Metrics

Excellent

Price to Earnings

21.89x

Market Capitalization

44.66 (Cr)

Industry P/E

33.97x

Growth Metrics

Poor

YoY Quarterly Profit Growth

3.70%
Poor

YoY Quarterly Sales Growth

1.62%
Excellent

Sales Growth (5Y)

34.28%
Excellent

EPS Growth (5Y)

40.00%
Excellent

Profit Growth (5Y)

40.00%

Financial Health

Poor

Debt to Equity

1.90x
Poor

Interest Coverage

1.96x
Poor

Free Cash Flow (5Y)

-5.59 (Cr)

Ownership Structure

Average

Promoter Holding

48.03%
Poor

FII Holding

0.25%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
48.03%
Promoter Holding
44.66 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of ROOPAIND across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Attractive Valuation (P/E: 21.89 vs Industry: 33.97)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Consistent Growth Track Record (34.28% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Excellent EPS Growth (40.00% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.

Strong Profit Growth Track Record (40.00% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

7 factors identified

Elevated Debt Levels (D/E: 1.90)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability and cash flow generation.

Weak Interest Coverage (1.96x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.

Negative Free Cash Flow (₹-5.59 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Limited Institutional Interest (FII+DII: 0.25%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

High Debt-to-Equity Ratio

Observation: Elevated financial risk due to high leverage.

Analysis: High debt levels may strain cash flows and increase financial risk during economic downturns.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

📊 Educational Market Overview

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.

Loading Peer Comparison

Finding companies in the Pharmaceuticals sector...

Financial Statements

Comprehensive financial data for Roopa Industries

About ROOPAIND

Company Details

Symbol:ROOPAIND
Industry:Pharmaceuticals & Biotechnology
Sector:Pharmaceuticals

Market Information

Market Cap:44.66 (Cr)
P/E Ratio:21.89
Beta:N/A

Performance

52W High:N/A
52W Low:N/A
Dividend Yield:0.00%

ROOPAIND Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)12.07%
Return on Capital Employed11.96%
Operating Profit Margin (5Y)5.36%
Debt to Equity Ratio1.90
Interest Coverage Ratio1.96

Growth & Valuation

Sales Growth (5Y)34.28%
Profit Growth (5Y)40.00%
EPS Growth (5Y)40.00%
YoY Quarterly Profit Growth3.70%
YoY Quarterly Sales Growth1.62%

Frequently Asked Questions

What is the current price of ROOPAIND?

ROOPAIND is currently trading at ₹56.29 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of ROOPAIND shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.

What is the P/E ratio of ROOPAIND and what does it mean?

ROOPAIND has a P/E ratio of 21.89x compared to the industry average of 33.97x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹22 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.

How is ROOPAIND performing according to Bull Run's analysis?

ROOPAIND has a Bull Run fundamental score of 44.6/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 12.07%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.

What sector and industry does ROOPAIND belong to?

ROOPAIND operates in the Pharmaceuticals & Biotechnology industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Roopa Industries. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.

What is Return on Equity (ROE) and why is it important for ROOPAIND?

ROOPAIND has an ROE of 12.07%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Roopa Industries generates profits from shareholders' equity. An ROE of 12% means the company generates ₹12 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.

How is ROOPAIND's debt-to-equity ratio and what does it indicate?

ROOPAIND has a debt-to-equity ratio of 1.90, which indicates high leverage that increases financial risk. This means the company has ₹190 of debt for every ₹100 of equity. Higher leverage can amplify returns during good times but increases bankruptcy risk during downturns.

What is ROOPAIND's dividend yield and is it a good dividend stock?

ROOPAIND offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.

How has ROOPAIND grown over the past 5 years?

ROOPAIND has achieved 5-year growth rates of: Sales Growth 34.28%, Profit Growth 40.00%, and EPS Growth 40.00%. This consistent double-digit growth indicates a strong business model and competitive positioning. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.

What is the promoter holding in ROOPAIND and why does it matter?

Promoters hold 48.03% of ROOPAIND shares, with 0.00% of promoter shares pledged. This promoter holding level suggests balanced ownership between management and public shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.

How does ROOPAIND compare with its industry peers?

ROOPAIND trades at P/E 21.89x vs industry average 33.97x, with ROE of 12.07% and ROCE of 11.96%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether ROOPAIND is outperforming its competitive set in profitability, growth, and valuation metrics.

What is ROOPAIND's market capitalization and what category does it fall into?

ROOPAIND has a market capitalization of ₹45 crores, making it a Small-cap stock. Small-cap stocks offer high growth potential but with higher volatility and risk. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.

What are the key financial ratios to consider for ROOPAIND?

Key ratios for ROOPAIND: ROE 12.07% (Good), ROCE 11.96%, P/E 21.89x, Debt-to-Equity 1.90, Interest Coverage 1.96x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.

How volatile is ROOPAIND stock and what is its beta?

ROOPAIND has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.

What is the 52-week high and low for ROOPAIND?

ROOPAIND has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹56.29, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.

What are the key risks associated with investing in ROOPAIND?

Key risks for ROOPAIND include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 1.90), and operational challenges. The stock has a Fundamental Score of 44.6/100, indicating higher risk requiring thorough due diligence. Sector-specific risks in Pharmaceuticals & Biotechnology include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.

What is ROOPAIND's operating profit margin and how has it trended?

ROOPAIND has a 5-year average Operating Profit Margin (OPM) of 5.36%, which suggests room for improvement in operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.

How is ROOPAIND's quarterly performance in terms of sales and profit growth?

ROOPAIND's recent quarterly performance shows YoY Sales Growth of 1.62% and YoY Profit Growth of 3.70%. Growth rates indicate the current business trajectory and market demand. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.

What is the FII and DII holding pattern in ROOPAIND?

ROOPAIND has FII holding of 0.25% and DII holding of 0.00%, totaling 0.25% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.